Jiang Y, Zheng L, Zhang Y, Fan Z, Guo J, Yang J
Hypertens Res. 2024; 48(1):15-25.
PMID: 39501009
PMC: 11700847.
DOI: 10.1038/s41440-024-01951-w.
Kario K, Hoshide S, Mogi M
Hypertens Res. 2024; 47(12):3380-3382.
PMID: 39375511
DOI: 10.1038/s41440-024-01927-w.
Yan Q, Cheng M, Xu W, Cheng Y, Wu F, Wang Y
Hypertens Res. 2024; 47(11):2981-2988.
PMID: 39169148
PMC: 11534683.
DOI: 10.1038/s41440-024-01817-1.
Soares S, Diniz M, Davino D, Albieri F, Santos A, Jesus E
Front Pharmacol. 2024; 15:1348917.
PMID: 38666030
PMC: 11043597.
DOI: 10.3389/fphar.2024.1348917.
Wang J, Palmer B, Vogel Anderson K, Sever P
J Clin Hypertens (Greenwich). 2023; 25(9):801-807.
PMID: 37551050
PMC: 10497034.
DOI: 10.1111/jch.14709.
Control status of ambulatory blood pressure and its relationship with arterial stiffness in the China nationwide registry of treated hypertensive patients: the REACTION-ABP study.
Li M, Zhang D, Tang S, Zheng Q, Huang Q, Sheng C
Hypertens Res. 2023; 46(10):2302-2311.
PMID: 37308551
PMC: 10258484.
DOI: 10.1038/s41440-023-01336-5.
Nighttime home blood pressure lowering effect of esaxerenone in patients with uncontrolled nocturnal hypertension: the EARLY-NH study.
Kario K, Nishizawa M, Kato M, Ishii H, Uchiyama K, Nagai M
Hypertens Res. 2023; 46(7):1782-1794.
PMID: 37173430
PMC: 10319630.
DOI: 10.1038/s41440-023-01292-0.
Interventions for reducing blood pressure in prehypertension: A meta-analysis.
Li W, Liu H, Wang X, Liu J, Xiao H, Wang C
Front Public Health. 2023; 11:1139617.
PMID: 37033077
PMC: 10078829.
DOI: 10.3389/fpubh.2023.1139617.
Home blood pressure-lowering effect of digital therapeutics in hypertension: impact of body weight and salt intake.
Kario K, Tomitani N, Harada N, Okura A, Hisaki F, Tanigawa T
Hypertens Res. 2023; 46(5):1181-1187.
PMID: 36899182
DOI: 10.1038/s41440-023-01245-7.
Impact of diabetic status and contribution of office and home blood pressure across diabetic status for cardiovascular disease: the J-HOP study.
Suzuki D, Hoshide S, Kario K
Hypertens Res. 2023; 46(7):1684-1693.
PMID: 36890269
DOI: 10.1038/s41440-023-01242-w.
Office and out-of-office blood pressure measurement using an all-in-one device.
Li M, Li Y
Hypertens Res. 2023; 46(4):1058-1060.
PMID: 36690810
DOI: 10.1038/s41440-022-01154-1.
Central hypertension is a non-negligible cardiovascular risk factor.
Cheng Y, Li Y, Cheng H, Siddique S, Huynh M, Sukonthasarn A
J Clin Hypertens (Greenwich). 2022; 24(9):1174-1179.
PMID: 36196474
PMC: 9532928.
DOI: 10.1111/jch.14561.
The HOPE Asia Network activity 2022: Towards better hypertension management in Asia.
Kario K, Chia Y, Wang J
J Clin Hypertens (Greenwich). 2022; 24(9):1109-1111.
PMID: 36196466
PMC: 9532905.
DOI: 10.1111/jch.14545.
The HOPE Asia network 2022 up-date consensus statement on morning hypertension management.
Kario K, Wang J, Chia Y, Wang T, Li Y, Siddique S
J Clin Hypertens (Greenwich). 2022; 24(9):1112-1120.
PMID: 36196465
PMC: 9532929.
DOI: 10.1111/jch.14555.
Seven-action approaches for the management of hypertension in Asia - The HOPE Asia network.
Kario K, Chia Y, Siddique S, Turana Y, Li Y, Chen C
J Clin Hypertens (Greenwich). 2022; 24(3):213-223.
PMID: 35172037
PMC: 8925006.
DOI: 10.1111/jch.14440.